Acta Haematologica Polonica provides interdisciplinary assistance in the fields of oncology, experimental haematology, laboratory haematology, cytometry, coagulation studies, transfusion medicine, and transplantology. The journal publishes original experimental papers, case studies and review articles. We also publish recommendations and guidelines of specialist teams of Polish and international haematologists and transfusion specialists.
Papers published in Acta Haematologica Polonica cover specifically such topics as physiology and pathology in haematology and transfusion, focusing on the following areas:
mechanisms of haemostasis
clinical aspects of hyperplastic haematological diseases
new advances in therapy
Authors of papers published in Acta Haematologica Polonica are researchers from leading clinical and academic centres. Target readership of the journal includes both medical doctors practicing medicine at research level as well as those working in clinics.
Acta Haematologica Polonica is the official journal of the Polish Society of Haematology and Blood Transfusion, and the Institute of Haematology and Transfusion Medicine, associated with Polish haematology and (blood) transfusion since 1970.
Articles submitted to the journal are first classified by Section Editor and then evaluated using the double blind peer review method. Articles in both Polish and English are accepted for publication. In addition to regular issues, the Editorial office prepares special issues associated with key conferences in the field.
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Editor-in-Chief Prof. dr hab. n. med. Jan Styczyński, Collegium Medicum, Nicolaus Copernicus University, Poland
Associate Editor-in-Chief Prof. dr hab. n. med. Ewa Lech-Marańda
Secretary Dr n. med. Agnieszka Karczmarczyk
Associate Editors Prof. dr hab. Tomasz Szczepański – pediatric hematooncology, molecular biology Prof. dr hab. Sebastian Giebel – transplantology Prof. dr hab. Iwona Hus – lymphoproliferations Prof. dr hab. Lidia Gil – acute leukemia, myeloproliferations Prof. dr hab. Magdalena Łętowska – transfusion medicine Dr hab. Joanna Rupa-Matysek – non-malignant hematology Dr hab. Andrzej Mital – hemostasis Dr n. med. Tomasz Stokłosa – molecular biology, leukemogenesis
Statistical Editor Prof. dr hab. Andrzej Tukiendorf, Department of Public Health, Wrocław Medical University, Wrocaw, Poland
International Advisory Board Prof. Jane Apperley, Department of Haemotology, Imperial College London, UK Prof. Zwi N. Berneman, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerpen, Belgium Prof. Alain Berrebi, Israel Hematology Institute, Kaplan Medical Center, Tel Aviv University, Rehovot, Israel Dr. Cedrik Britten, Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz, Germany Prof. Lars Bullinger, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charité – University of Berlin, Germany Prof. dr hab. n. med. Krzysztof Giannopoulos, Department of Experimental Hematooncology, Medical University of Lublin; Hematology Department, Lublin Oncology Center in Lublin Prof. Jakub Gołąb, Department of Immunology, Medical University of Warsaw, Poland Prof. Andrzej Hellmann, Department of Hematology and Transplantation, Medical University of Gdansk, Poland Prof. Andrzej Jakubowiak, Department of Medicine, University of Chicago Medical Center, Chicago, USA Prof. Wiesław Jędrzejczak, Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland Prof. Przemysław Juszczyński, Department of Hematology, Institute of Hematology and Blood Transfusion Medicine, Medical University of Warsaw, Poland Prof. Anna Korycka-Wołowiec, Department of Hematology, Medical University of Lodz, Poland Prof. Sławomira Kyrcz-Krzemień, Dept. of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland Prof. Krzysztof Lewandowski, Department of Haematology and Proliferative Diseases of Hematopoietic System, Medical University of Poznan, Poland Prof. Per Ljungman, Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, and Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden Prof. Maciej Machaczka, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden Prof. Grzegorz Mazur, Department and Clinic of Internal and Occupational Diseases and Hypertension, Medical University of Wroclaw, Poland Prof. Jaroslav Michalek, Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic Prof. Ken Mills, Blood Cancer Research Group, Centre for Cancer Research and Cell Biology, Queens University Belfast, UK. Dr hab. Beata Piątkowska-Jakubas, Department and Clinic of Haematology, Jagiellonian University Medical College, Krakow, Poland Prof. Maria Podolak-Dawidziak, Department of Hematology, Blood Cancer and Bone Marrow Transplantation, Medical University of Wroclaw, Poland Prof. Aaron Polliack, Dept.of Hematology, Hebrew University Hadassah Medical School, Jerusalem, Israel Prof. Mariusz Ratajczak, Department of Medicine, Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky Prof. Tadeusz Robak, Department of Hematology, Medical University of Lodz, Poland Prof. Jacek Roliński, Department of Clinical Immunology, Medical University of Lublin, Poland Prof. Michael Schmitt, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany Prof. Aleksander Skotnicki, Department and Clinic of Haematology, Jagiellonian University Medical College, Krakow, Poland Prof. Viggo F.I. Van Tendeloo, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Belgium Prof. Jacek Wachowiak, Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Poznan, Poland Prof. Jan Walewski, Maria Sklodowska-Curie Memorial Institute-Centre of Oncology, Warsaw, Poland Prof. Krzysztof Warzocha, Hematology Unit, Regional Hospital in Kołobrzeg, Poland Prof. Peter H. Wiernik, Cancer Research Foundation of New York, Chappaqua, USA Prof. Dominik Wolf, Department of Hematology, Oncology and Rheumatology, Center of Integrated Oncology Cologne Bonn, University Hospital of Bonn, Germany Prof. Dariusz Wołowiec, Department and Clinic of Haematology, Blood Neoplasm and Bone Marrow Transplantation, Medical University of Wroclaw, Poland Prof. Thorsten Zenz, Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Editor's Address Department of Pediatrics, Hematology and Oncology Collegium Medicum, Nicolaus Copernicus University University Hospital No. 1 ul. Skłodowskiej-Curie 9 85-094 Bydgoszcz fax 52 585 4087 e-mail: firstname.lastname@example.org
Publisher De Gruyter Poland Bogumiła Zuga 32A Str. 01-811 Warsaw, Poland T: +48 22 701 50 15